Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
3 days ago
Among patients with moderate-to-severe psoriasis, the use of biologics appears to lower the risk of being hospitalized for the novel coronavirus disease (COVID-19), a new study has found.

Anxiety in MCI may lead to Alzheimer’s disease

Roshini Claire Anthony
01 Jan 2021

Anxiety symptoms in patients with mild cognitive impairment (MCI) may increase their risk of developing Alzheimer’s disease, according to a study presented at the Radiological Society of North America annual meeting (RSNA 2020).

“[Patients with MCI and anxiety symptoms] developed Alzheimer’s disease faster than individuals without anxiety, independently of whether they had a genetic risk factor for Alzheimer’s disease or brain volume loss,” said study first author Jenny Ulber, a medical student at the Medical University of South Carolina (MUSC) in Charleston, South Carolina, US.

The investigators enrolled 339 elderly individuals (mean age 72 years) with MCI from the US-based Alzheimer’s Disease Neuroimaging Initiative 2 cohort. Seventy-two of these patients progressed to develop Alzheimer’s disease while the remaining 267 had stable MCI. The Neuropsychiatric Inventory (NPI) and Geriatric Depression Scale (GDS) anxiety scores were used to assess symptoms of anxiety and depression, respectively. Magnetic resonance imaging (MRI) of the brain was carried out at baseline to identify hippocampal and entorhinal cortex volumes (normalized to baseline intracranial volume).

Age, sex, and years of education did not differ between patients with MCI who remained stable or progressed to Alzheimer’s disease. [RSNA 2020, abstract SSNR05-06]

Patients who progressed to Alzheimer’s disease had significantly lower normalized hippocampal and entorhinal cortex volumes than those who did not develop Alzheimer’s disease (p<0.001 for both). Patients who developed Alzheimer’s disease also had greater frequency of the ApoE4 allele and higher maximum levels of anxiety and depression than those who did not develop Alzheimer’s disease (p<0.001 for both). 

Analysis showed that higher levels of anxiety (p<0.001), the presence of the ApoE4 allele (p<0.001), and lower hippocampal and entorhinal cortex volumes (p=0.019 and p=0.004, respectively) were predictors of the progression from MCI to Alzheimer’s disease.

“[W]e found that anxiety, genetic risk factors, and changes in brain volume are independently associated with increased rate of progression to dementia,” said Ulber.

“We know that volume loss in certain areas of the brain is a factor that predicts progression to Alzheimer’s disease,” said senior author Dr Maria Vittoria Spampinato, an assistant professor in radiology at MUSC.

“[W]e wanted to see if anxiety had an effect on brain structure, or if the effect of anxiety was independent from brain structure in favouring the progression of disease,” she said.

According to Spampinato, the results highlight the importance of taking a closer look at the anxiety-cognition link.

“We don’t know yet if the anxiety is a symptom – in other words, their memory is getting worse and they become anxious – or if anxiety contributes to cognitive decline,” she said. “If we were able in the future to find that anxiety is actually causing progression, then we should more aggressively screen for anxiety disorders in the elderly.”

“The geriatric population is routinely screened for depression in many hospitals, but perhaps this vulnerable population should also be assessed for anxiety disorders,” added Ulber. “Recognizing and treating anxiety could prove useful to slow cognitive decline.”

“Middle-aged and elderly individuals with high level of anxiety may benefit from intervention, whether it be pharmacological or cognitive behavioural therapy, with the goal of slowing cognitive decline,” she said.

The authors also noted that follow-up MRIs may paint a clearer picture of the connection between anxiety and brain structure. “We’re now interested in looking at changes over time to see if anxiety has an effect one way or the other on how fast the brain damage progresses,” said Spampinato. “We will also take a closer look at gender differences in the association between anxiety and cognitive decline.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
3 days ago
Among patients with moderate-to-severe psoriasis, the use of biologics appears to lower the risk of being hospitalized for the novel coronavirus disease (COVID-19), a new study has found.